BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 36912618)

  • 21. Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma: An Update on Heterogeneity and Therapeutic Targeting.
    Vaish U; Jain T; Are AC; Dudeja V
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment.
    Nihashi Y; Song X; Yamamoto M; Setoyama D; Kida YS
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer.
    Yu Y; Schuck K; Friess H; Kong B
    Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17A-producing CD8
    Picard FSR; Lutz V; Brichkina A; Neuhaus F; Ruckenbrod T; Hupfer A; Raifer H; Klein M; Bopp T; Pfefferle PI; Savai R; Prinz I; Waisman A; Moos S; Chang HD; Heinrich S; Bartsch DK; Buchholz M; Singh S; Tu M; Klein L; Bauer C; Liefke R; Burchert A; Chung HR; Mayer P; Gress TM; Lauth M; Gaida M; Huber M
    Gut; 2023 Aug; 72(8):1510-1522. PubMed ID: 36759154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment.
    Xue M; Zhu Y; Jiang Y; Han L; Shi M; Su R; Wang L; Xiong C; Wang C; Wang T; Deng S; Wu D; Cao Y; Dong L; Bai F; Zhao S; Deng X; Peng C; Li H; Chen J; Shen B; Jiang L; Chen H
    Nat Commun; 2023 Jul; 14(1):4600. PubMed ID: 37524695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts.
    Liu H; Shi Y; Qian F
    Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transfer Learning Reveals Cancer-Associated Fibroblasts Are Associated with Epithelial-Mesenchymal Transition and Inflammation in Cancer Cells in Pancreatic Ductal Adenocarcinoma.
    Guinn S; Kinny-Köster B; Tandurella JA; Mitchell JT; Sidiropoulos DN; Loth M; Lyman MR; Pucsek AB; Zabransky DJ; Lee JW; Kartalia E; Ramani M; Seppälä TT; Cherry C; Suri R; Zlomke H; Patel J; He J; Wolfgang CL; Yu J; Zheng L; Ryan DP; Ting DT; Kimmelman A; Gupta A; Danilova L; Elisseeff JH; Wood LD; Stein-O'Brien G; Kagohara LT; Jaffee EM; Burkhart RA; Fertig EJ; Zimmerman JW
    Cancer Res; 2024 May; 84(9):1517-1533. PubMed ID: 38587552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma.
    Pan X; Zhou J; Xiao Q; Fujiwara K; Zhang M; Mo G; Gong W; Zheng L
    J Hematol Oncol; 2021 Nov; 14(1):184. PubMed ID: 34727952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesenchymal Lineage Heterogeneity Underlies Nonredundant Functions of Pancreatic Cancer-Associated Fibroblasts.
    Helms EJ; Berry MW; Chaw RC; DuFort CC; Sun D; Onate MK; Oon C; Bhattacharyya S; Sanford-Crane H; Horton W; Finan JM; Sattler A; Makar R; Dawson DW; Xia Z; Hingorani SR; Sherman MH
    Cancer Discov; 2022 Feb; 12(2):484-501. PubMed ID: 34548310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CAF Subpopulations: A New Reservoir of Stromal Targets in Pancreatic Cancer.
    Pereira BA; Vennin C; Papanicolaou M; Chambers CR; Herrmann D; Morton JP; Cox TR; Timpson P
    Trends Cancer; 2019 Nov; 5(11):724-741. PubMed ID: 31735290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
    Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K
    Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CXCR2 signaling promotes secretory cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.
    Awaji M; Saxena S; Wu L; Prajapati DR; Purohit A; Varney ML; Kumar S; Rachagani S; Ly QP; Jain M; Batra SK; Singh RK
    FASEB J; 2020 Jul; 34(7):9405-9418. PubMed ID: 32453916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palladin isoforms 3 and 4 regulate cancer-associated fibroblast pro-tumor functions in pancreatic ductal adenocarcinoma.
    Alexander JI; Vendramini-Costa DB; Francescone R; Luong T; Franco-Barraza J; Shah N; Gardiner JC; Nicolas E; Raghavan KS; Cukierman E
    Sci Rep; 2021 Feb; 11(1):3802. PubMed ID: 33589694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meflin-Positive Cancer-Associated Fibroblasts Inhibit Pancreatic Carcinogenesis.
    Mizutani Y; Kobayashi H; Iida T; Asai N; Masamune A; Hara A; Esaki N; Ushida K; Mii S; Shiraki Y; Ando K; Weng L; Ishihara S; Ponik SM; Conklin MW; Haga H; Nagasaka A; Miyata T; Matsuyama M; Kobayashi T; Fujii T; Yamada S; Yamaguchi J; Wang T; Woods SL; Worthley D; Shimamura T; Fujishiro M; Hirooka Y; Enomoto A; Takahashi M
    Cancer Res; 2019 Oct; 79(20):5367-5381. PubMed ID: 31439548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent advances in understanding cancer-associated fibroblasts in pancreatic cancer.
    Huang H; Brekken RA
    Am J Physiol Cell Physiol; 2020 Aug; 319(2):C233-C243. PubMed ID: 32432930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer.
    Dings MPG; Manoukian P; Waasdorp C; Quik JSE; Strijker M; Lodestijn SC; van Neerven SM; Moreno LF; de Oliveira RL; Bonsing BA; Bruno MJ; Busch OR; Doukas M; van Eijck CH; Mohammad NH; de Hingh IH; Molenaar QI; Besselink MG; Vermeulen L; Medema JP; van Laarhoven HWM; Bijlsma MF
    Int J Cancer; 2023 Feb; 152(3):511-523. PubMed ID: 36069222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity and plasticity of cancer-associated fibroblasts in the pancreatic tumor microenvironment.
    Boyd LNC; Andini KD; Peters GJ; Kazemier G; Giovannetti E
    Semin Cancer Biol; 2022 Jul; 82():184-196. PubMed ID: 33737108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of steady-state fibroblast subtypes in the normal human breast as cells-of-origin for perturbed-state fibroblasts in breast cancer.
    Bagger MM; Sjölund J; Kim J; Kohler KT; Villadsen R; Jafari A; Kassem M; Pietras K; Rønnov-Jessen L; Petersen OW
    Breast Cancer Res; 2024 Jan; 26(1):11. PubMed ID: 38229104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts.
    Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P
    Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow-derived macrophages converted into cancer-associated fibroblast-like cells promote pancreatic cancer progression.
    Iwamoto C; Ohuchida K; Shinkawa T; Okuda S; Otsubo Y; Okumura T; Sagara A; Koikawa K; Ando Y; Shindo K; Ikenaga N; Nakata K; Moriyama T; Miyasaka Y; Ohtsuka T; Eto M; Akashi K; Nakamura M
    Cancer Lett; 2021 Aug; 512():15-27. PubMed ID: 33961925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.